Thinh Q. Pham

1.7k total citations · 1 hit paper
10 papers, 1.3k citations indexed

About

Thinh Q. Pham is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Thinh Q. Pham has authored 10 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Cancer Research. Recurrent topics in Thinh Q. Pham's work include Molecular Biology Techniques and Applications (3 papers), HER2/EGFR in Cancer Research (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Thinh Q. Pham is often cited by papers focused on Molecular Biology Techniques and Applications (3 papers), HER2/EGFR in Cancer Research (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Thinh Q. Pham collaborates with scholars based in United States, Canada and United Kingdom. Thinh Q. Pham's co-authors include Howard M. Stern, Xander Munroe, Mark X. Sliwkowski, Evelyn Yao, Lisa Crocker, Klaus P. Hoeflich, Si Tuen Lee-Hoeflich, David A. Eberhard, Guy Cavet and Somasekar Seshagiri and has published in prestigious journals such as Journal of Clinical Oncology, Nature Methods and Cancer Research.

In The Last Decade

Thinh Q. Pham

10 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Central Role for HER3 in HER2 -Amplified Breast Cancer: Implications for Targeted Therapy

2008 501 citations Si Tuen Lee-Hoeflich, Lisa Crocker et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thinh Q. Pham United States	8	913	629	411	303	183	10	1.3k
Samuel W. Brady United States	14	588 0.6×	608 1.0×	190 0.5×	188 0.6×	187 1.0×	25	1.1k
Angelica Fasolo Italy	18	856 0.9×	674 1.1×	146 0.4×	390 1.3×	284 1.6×	43	1.5k
Jonathan R. Reeves United Kingdom	9	691 0.8×	500 0.8×	445 1.1×	193 0.6×	192 1.0×	13	1.2k
Douglas P. Calvin United States	7	396 0.4×	548 0.9×	180 0.4×	315 1.0×	433 2.4×	12	1.1k
Jennifer Vermette United States	8	712 0.8×	334 0.5×	304 0.7×	305 1.0×	86 0.5×	14	964
S S Bacus United States	14	549 0.6×	366 0.6×	313 0.8×	133 0.4×	141 0.8×	16	838
Shaveta Vinayak United States	15	790 0.9×	429 0.7×	104 0.3×	239 0.8×	351 1.9×	45	1.2k
Mythili Shastry United States	15	706 0.8×	396 0.6×	285 0.7×	235 0.8×	291 1.6×	38	1.2k
Analía Azaro Spain	18	557 0.6×	569 0.9×	61 0.1×	295 1.0×	198 1.1×	56	1.1k
Xenia Jimenez United States	22	670 0.7×	1.2k 1.9×	630 1.5×	227 0.7×	280 1.5×	27	1.7k

Countries citing papers authored by Thinh Q. Pham

Since Specialization

Citations

This map shows the geographic impact of Thinh Q. Pham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thinh Q. Pham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thinh Q. Pham more than expected).

Fields of papers citing papers by Thinh Q. Pham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thinh Q. Pham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thinh Q. Pham. The network helps show where Thinh Q. Pham may publish in the future.

Co-authorship network of co-authors of Thinh Q. Pham

This figure shows the co-authorship network connecting the top 25 collaborators of Thinh Q. Pham. A scholar is included among the top collaborators of Thinh Q. Pham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thinh Q. Pham. Thinh Q. Pham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Sahu, Nisebita, Emily Chan, Felix Chu, et al.. (2017). Cotargeting of MEK and PDGFR/STAT3 Pathways to Treat Pancreatic Ductal Adenocarcinoma. Molecular Cancer Therapeutics. 16(9). 1729–1738. 26 indexed citations

2.

Wilson, Catherine, Thinh Q. Pham, Xiaofen Ye, et al.. (2014). Abstract 693: AXL tyrosine kinase inhibition selectively sensitizes mesenchymal cancer cells to antimitotic agents. Cancer Research. 74(19_Supplement). 693–693. 1 indexed citations

3.

Modrek, Barmak, Lin Ge, Ajay Pandita, et al.. (2009). Oncogenic Activating Mutations Are Associated with Local Copy Gain. Molecular Cancer Research. 7(8). 1244–1252. 51 indexed citations

4.

Galindo, Cristi L., Michael A. Skinner, Mounir Errami, et al.. (2009). Transcriptional profile of isoproterenol-induced cardiomyopathy and comparison to exercise-induced cardiac hypertrophy and human cardiac failure. BMC Physiology. 9(1). 23–23. 86 indexed citations

5.

Lee-Hoeflich, Si Tuen, Lisa Crocker, Evelyn Yao, et al.. (2008). A Central Role for HER3 in HER2 -Amplified Breast Cancer: Implications for Targeted Therapy. Cancer Research. 68(14). 5878–5887. 501 indexed citations breakdown →

6.

Peters, Brock A., Zhengyan Kan, Dragan Sebisanovic, et al.. (2007). Highly efficient somatic-mutation identification using Escherichia coli mismatch-repair detection. Nature Methods. 4(9). 713–715. 5 indexed citations

7.

Jubb, Adrian M., Thinh Q. Pham, Gretchen Frantz, Franklin Peale, & Kenneth J. Hillan. (2006). Quantitative <I>In Situ</I> Hybridization of Tissue Microarrays. Humana Press eBooks. 326. 255–264. 13 indexed citations

8.

Gordon, Michael S., Daniela Matei, Carol Aghajanian, et al.. (2006). Clinical Activity of Pertuzumab (rhuMAb 2C4), a HER Dimerization Inhibitor, in Advanced Ovarian Cancer: Potential Predictive Relationship With Tumor HER2 Activation Status. Journal of Clinical Oncology. 24(26). 4324–4332. 187 indexed citations

9.

Yauch, Robert L., Thomas Januario, David A. Eberhard, et al.. (2005). Epithelial versus Mesenchymal Phenotype Determines In vitro Sensitivity and Predicts Clinical Activity of Erlotinib in Lung Cancer Patients. Clinical Cancer Research. 11(24). 8686–8698. 415 indexed citations

10.

Frantz, Gretchen, Thinh Q. Pham, Franklin Peale, & Kenneth J. Hillan. (2001). Detection of novel gene expression in paraffin-embedded tissues by isotopicin situ hybridization in tissue microarrays. The Journal of Pathology. 195(1). 87–96. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact